Suppr超能文献

全国范围内药师主导的电话随访计划对改善近期骨折老年女性骨质疏松症管理的评估。

Evaluation of a Nationwide Pharmacist-Led Phone Outreach Program to Improve Osteoporosis Management in Older Women with Recently Sustained Fractures.

机构信息

OptumRx, 2300 Main St., Irvine, CA 92614.

出版信息

J Manag Care Spec Pharm. 2015 Sep;21(9):803-10. doi: 10.18553/jmcp.2015.21.9.803.

Abstract

BACKGROUND

Osteoporosis-related fractures are a considerable economic burden on the U.S. health care system. Since 2008, the Centers for Medicare Medicaid Services have adopted a Medicare Part C Five-Star Quality Rating measure to ensure that a woman's previously unaddressed osteoporosis is managed appropriately after a fracture. Despite the effort to improve this gap in care, the 2013 CMS plan ratings fact sheet reported an average star rating of 1.4 stars for the osteoporosis measure, the lowest score for any measure across all health plans.

OBJECTIVE

To evaluate the impact of conducting a pharmacist-led, telephone outreach program to members or their providers to improve osteoporosis management in elderly women after experiencing fractures.

METHODS

This was a prospective, randomized study to evaluate the effectiveness of 3 different intervention strategies within a nationwide managed care population. Women aged 66 years and older who experienced a new bone fracture between January 1, 2012-August 31, 2012, were identified through medical claims. Women who were treated with an osteoporosis medication or received a bone mineral density (BMD) test within a year of their fractures were excluded. Study patients were randomized into 3 intervention cohorts: (1) baseline intervention consisting of member educational mailing and provider educational mail or fax notification; (2) baseline intervention plus a live outbound intervention call to members by a pharmacist; and (3) baseline intervention plus a pharmacist call to members' providers to recommend starting osteoporosis therapy and/or a bone mineral density (BMD) test. An intent-to-treat and per protocol analyses were employed, and appropriate osteoporosis management (initiation of osteoporosis therapy and/or BMD testing) 120 days after the baseline intervention and 180 days after a fracture were measured.

RESULTS

The study identified 6,591 members who were equally randomized into 3 cohorts. The baseline demographics in each cohort were similar. Results of the intent-to-treat analysis showed more members in cohort 3 receiving appropriate osteoporosis management (13.0%) compared with those in cohort 2 (10.3%, P  less than  0.005) or compared with those in cohort 1 (9.1%, P  less than  0.001). No difference was detected between those receiving additional member calls (cohort 2) and those receiving only the baseline intervention (cohort 1). Similar results were observed utilizing the 180 days after fracture time frame.

CONCLUSIONS

The effectiveness of a pharmacist-led telephone intervention directed at providers or members was examined in this randomized study. Pharmacist calls to members did not improve osteoporosis management over member and provider mail and fax notifications. Greater impact was demonstrated by performing a pharmacist call intervention with providers rather than with members.

摘要

背景

骨质疏松性骨折给美国医疗保健系统带来了相当大的经济负担。自 2008 年以来,医疗保险和医疗补助服务中心采用了医疗保险 C 部分五星级质量评级措施,以确保女性在骨折后得到适当的治疗。尽管努力改善这一护理差距,但 2013 年 CMS 计划评级情况说明书报告称,骨质疏松症措施的平均星级评分为 1.4 星,是所有医疗计划中所有措施中得分最低的。

目的

评估开展药剂师主导的电话外展计划对经历骨折的老年女性骨质疏松症管理的影响。

方法

这是一项前瞻性、随机研究,评估了全国范围内管理式医疗人群中 3 种不同干预策略的有效性。通过医疗索赔确定 2012 年 1 月 1 日至 2012 年 8 月 31 日期间发生新骨折的 66 岁及以上女性。在骨折一年内接受骨质疏松症药物治疗或接受骨密度(BMD)检测的女性被排除在外。研究患者被随机分为 3 个干预组:(1)基线干预,包括成员教育邮寄和提供者教育邮件或传真通知;(2)基线干预加药剂师对成员的现场外展电话;(3)基线干预加药剂师致电成员的提供者,建议开始骨质疏松症治疗和/或进行骨密度(BMD)测试。采用意向治疗和方案分析,并在基线干预后 120 天和骨折后 180 天测量适当的骨质疏松症管理(开始骨质疏松症治疗和/或 BMD 测试)。

结果

该研究确定了 6591 名成员,他们被平均随机分配到 3 个队列中。每个队列的基线人口统计学特征相似。意向治疗分析结果显示,第 3 组中有更多的成员接受了适当的骨质疏松症管理(13.0%),而第 2 组(10.3%,P<0.005)或第 1 组(9.1%,P<0.001)。与仅接受基线干预的第 1 组(9.1%,P<0.001)相比,接受额外成员电话的成员(第 2 组)之间没有差异。在骨折后 180 天的时间框架内观察到了类似的结果。

结论

在这项随机研究中,对药剂师主导的针对提供者或成员的电话干预的有效性进行了检查。药剂师致电成员并未改善成员和提供者邮件和传真通知的骨质疏松症管理。与针对成员的干预相比,针对提供者的药剂师电话干预产生了更大的影响。

相似文献

2
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
4
Impact of a pharmacist-directed intervention in postmenopausal women after fracture.
Am J Health Syst Pharm. 2012 Mar 15;69(6):504-9. doi: 10.2146/ajhp110309.
5
A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
J Manag Care Spec Pharm. 2016 May;22(5):526-38. doi: 10.18553/jmcp.2016.22.5.526.
6
A pharmacist-run anabolic osteoporosis clinic: An abaloparatide descriptive report.
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):593-597. doi: 10.1016/j.japh.2019.03.017. Epub 2019 May 14.
7
Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
J Manag Care Spec Pharm. 2014 Dec;20(12):1193-203. doi: 10.18553/jmcp.2014.20.12.1193.
8
Impact of Pharmacist-Physician Collaboration on Osteoporosis Treatment Rates.
Ann Pharmacother. 2018 Sep;52(9):876-883. doi: 10.1177/1060028018770622. Epub 2018 Apr 11.
9
Cancer patients with fractures are rarely assessed or treated for osteoporosis: a population-based study.
Osteoporos Int. 2021 Feb;32(2):333-341. doi: 10.1007/s00198-020-05596-6. Epub 2020 Aug 17.

引用本文的文献

3
Future challenges in rheumatology - is telemedicine the solution?
Ther Adv Musculoskelet Dis. 2022 Mar 17;14:1759720X221081638. doi: 10.1177/1759720X221081638. eCollection 2022.
4
Telehealth Interventions Designed for Women: an Evidence Map.
J Gen Intern Med. 2018 Dec;33(12):2191-2200. doi: 10.1007/s11606-018-4655-8. Epub 2018 Oct 3.

本文引用的文献

2
Patient perceptions of the path to osteoporosis care following a fragility fracture.
Qual Health Res. 2012 Dec;22(12):1647-58. doi: 10.1177/1049732312457467. Epub 2012 Aug 24.
4
Impact of a pharmacist-directed intervention in postmenopausal women after fracture.
Am J Health Syst Pharm. 2012 Mar 15;69(6):504-9. doi: 10.2146/ajhp110309.
5
An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients.
Health Aff (Millwood). 2012 Jan;31(1):120-9. doi: 10.1377/hlthaff.2011.0931.
6
The impact of pharmacist interventions on osteoporosis management: a systematic review.
Osteoporos Int. 2011 Oct;22(10):2587-96. doi: 10.1007/s00198-011-1661-7. Epub 2011 Jul 1.
7
Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients.
Osteoporos Int. 2011 Jul;22(7):2067-82. doi: 10.1007/s00198-011-1544-y. Epub 2011 May 24.
8
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.
10
Improving care of patients at-risk for osteoporosis: a randomized controlled trial.
J Gen Intern Med. 2007 Mar;22(3):362-7. doi: 10.1007/s11606-006-0099-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验